Multivalent Meditopes Enhance Antibody Antigen Internalization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current monoclonal antibodies face limitations such as adverse side effects due to off-target interactions and long circulation times, and may require internalization by cells to elicit a therapeutic response, highlighting the need for improved antibodies that enhance efficacy, specificity, and safety.
Innovation Solution
Development of meditope-enabled antibodies that specifically bind to cell-surface antigens, combined with multivalent meditopes to promote internalization and clustering of these antigens, thereby increasing therapeutic efficacy and reducing the amount of antibody required for a desired effect.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional monoclonal antibodies are used, then they can bind to cell-surface antigens, but they require long circulation times and may cause adverse side effects due to off-target interactions
Solution Approach 1:
The antibody is divided into separate functional components: a binding domain that recognizes the target antigen and an effector domain that mediates the therapeutic effect. This segmentation allows the binding portion to be small and specific while the effector functions are activated only upon target engagement, reducing circulation time and off-target effects
Solution Approach 2:
A multivalent meditope acts as an intermediary that bridges multiple antibody molecules bound to the target antigen. This intermediary structure promotes antigen clustering and internalization, enhancing therapeutic efficacy while allowing the antibodies to be cleared more rapidly from circulation after achieving their effect
2Reliability
If conventional monoclonal antibodies bind to cell-surface antigens, then they can achieve target recognition, but they may not effectively induce internalization to elicit therapeutic response
Solution Approach 1:
Multiple antibody molecules bound to the target antigen are merged through crosslinking by the multivalent meditope, creating a clustered complex that is efficiently internalized by the cell. This merging of multiple binding events into a single internalization event dramatically enhances the therapeutic response
Solution Approach 2:
The system transitions from static antibody binding to dynamic antigen clustering and internalization. The multivalent meditope enables the antibody-antigen complex to evolve from simple binding to active reorganization of the antigen on the cell surface, promoting its internalization and thereby enhancing therapeutic efficacy
3Reliability
If higher doses of conventional antibodies are administered to improve therapeutic effect, then efficacy may increase, but adverse side effects and off-target interactions increase
Solution Approach 1:
The therapeutic effect is extracted and concentrated at the target site through efficient internalization mechanisms. By designing the system to achieve maximal effect at the target with minimal circulating antibody, the harmful off-target interactions are effectively removed or minimized
Solution Approach 2:
The system changes the kinetic parameters of antibody action: instead of relying on long circulation and continuous binding, the design achieves rapid binding, fast internalization, and quick clearance. This parameter transformation allows high efficacy at low doses while minimizing the window for off-target interactions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of meditope-enabled antibodies with multivalent meditopes enhances the internalization and clustering of cell-surface antigens, leading to improved therapeutic outcomes by increasing the efficacy of antibody therapies and reducing side effects, allowing for lower dosages and more targeted delivery of therapeutic agents.
Implementation Method 1
a multivalent meditope, thereby promoting clustering of the cell-surface antigen on the surface of the target cell
Implementation Method 2
thereby promoting internalization of the cell-surface antigen on the surface of the target cell
Data Source
AI summary
Provided are methods for altering the distribution of a cell surface antigen. Also provided are compositions for use in the methods, including multivalent meditopes, and methods of producing, using, testing, and screening the same, including therapeutic and diagnostic methods and uses.